RE: Follow the money24 Sep 2022 17:37
Recommend watching the last interview again
https://www.youtube.com/watch?v=i2h0km6rZb0
There really is no reason for FDA not to approve the phase 3. They have worked alongside IMM to develop the protocol. It is safe. FDA have ALREADY approved the phase 3 protocol and furthermore the PK study they requested also came back very positively. The phase 3 trial could have started in 2021. The only reason it didn't was due to the FDA asking for the PK study and IMM delayed it to keep FDA happy and it would still have to be done at some point.
Also, note in FDA's response:
''In addition, the FDA also provided further significant guidance on the study protocol that can be amended to improve the regulatory outcome.''
The FDA are on our side. They want the trial to work hence for word 'improve'.
As I said before, the price action last week has nothing to do with any news. With SP now at 3p, there is no downside but massive upside. If no news on Monday, price to creep back up to 6-7p as we await the approval. Then upon approval, should see 15-20p. Hope nobody listened to Lambkins